This post was originally published on this site
(RTTNews) – Shares of clinical-stage drug discovery company Lixte Biotechnology Holdings, Inc. (LIXT) are rising more than 15% Tuesday morning after the company announced an agreement with cancer research and treatment center, City of Hope to begin Phase 1b study of LB-100 in small cell lung cancer.
The trial will assess the combination of Lixte’s first-in-class protein phosphatase inhibitor LB-100 with a standard regimen for untreated, extensive stage-disease small cell lung cancer (ED-SCLC).
LB-100 will be given in combination with carboplatin, etoposide and atezolizumab, an FDA approved but marginally effective regimen, in previously untreated ED-SCLC.
LIXT, currently at $3.61, has traded in the range of $0.80- $7.86 in the last one year.
Recommended articles
Morgan Stanley CEO James Gorman is now the highest-paid bank executive in America following a 22% raise amid a record year for the companyMorgan Stanley global CEO James Gorman. David Wong/South China Morning Post via Getty ImagesMorgan Stanley CEO James Gorman was paid $33 million in 2020, the bank said in a filing Friday. Gorman's pay...(read more)
Cansortium Announces Shares for Debt Settlement and Issuance of Stock OptionsMIAMI, Jan. 22, 2021 /PRNewswire/ - Cansortium Inc. (CSE : TIUM.U) (OTCQB : CNTMF) ("Cansortium" or the "Company"), a vertically integrated cannabis company with operations in Florida, Texas, Michigan...(read more)
Perpetual Energy Inc. Completes Note Exchange and Makes PIK Interest PaymentCALGARY, AB, Jan. 22, 2021 /CNW/ - (TSX: PMT) – Perpetual Energy Inc. ("Perpetual" or the "Company") announced today that it has completed its previously announced arrangement involving the exchange o...(read more)
Fast-Food Sensation Jollibee Continues Spreading Joy Across Canada with Two New Store Openings This WeekWEST COVINA, Calif., Jan. 22, 2021 /CNW/ -- Popular fast-food chain Jollibee, known for its unique and mouthwatering take on comfort food, is strengthening its footprint across Canada with the additio...(read more)
Bastion Balance Seoul, Korea.